Clovis Oncology Inc $46.08

down 0.00


12/9/2014 04:00 PM  |  NASDAQ : CLVS  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get CLVS Trend Analysis - it has underperformed the S&P 500 by 49%

Partner Headlines

  1. Morning Market Losers

    Benzinga
  2. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  3. US Stock Futures Flat Ahead Of Manufacturing PMI

    Benzinga
  4. Market Wrap For June 5: Markets Positive Before Friday's Employment Report

    Benzinga
  5. UPDATE: Stifel Upgrades Clovis Oncology On Favorable Risk/Reward

    Benzinga
  6. Market Wrap For June 4: Markets Slightly Higher On Light Volume, Beige ...

    Benzinga
  7. Citi Downgrades Clovis, Rates It As High Risk

    Benzinga
  8. Benzinga's Volume Movers

    Benzinga
  9. Benzinga's Top #PreMarket Gainers

    Benzinga
  10. UPDATE: Clovis Oncology Shares Rise 12% Premarket on Positive Phase 1 Trial ...

    Benzinga
  11. US Stock Futures Rise; GDP, Jobless Claims Data In Focus

    Benzinga
  12. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues Downbeat ...

    Benzinga
  13. Benzinga's Top Initiations

    Benzinga
  14. Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam Shares ...

    Benzinga
  15. Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook

    Benzinga
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. Clovis Oncology Announces 2014 Objectives, Financial Guidance

    Benzinga
  18. What The Top Stocks Of 2013 Had In Common

    IBD
  19. Clovis Oncology CO-1686 Clinical Data Accepted as Oral Presentation at ...

    Benzinga
  20. Clovis Oncology Announces 2M Share Offering by Selling Stockholders

    Benzinga
  21. Benzinga's M&A Chatter for Tuesday November 19, 2013

    Benzinga
  22. Why Clovis Oncology Was The Short Trade Of The Day

    Benzinga
  23. UPDATE: H.C. Wainwright nitiates on Clovis Oncology On Prospects Of CO-1686

    Benzinga
  24. Mid-Morning Market Update: Markets Mixed; Merck Profit Beats Estimates

    Benzinga
  25. Clovis Oncology's CO-1686 Demonstrates Promising Clinical Activity and ...

    Benzinga
  26. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  27. QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion ...

    Benzinga
  28. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network Shares ...

    Benzinga
  29. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net Profit ...

    Benzinga
  30. Mid-Day Market Update: US Stocks Turn Higher; MAKO Surgical Shares Surge ...

    Benzinga
  31. Mid-Morning Market Update: Markets Slip; AutoZone Q4 Net Profit Rises 15%

    Benzinga
  32. Morning Market Losers

    Benzinga
  33. Benzinga's M&A Chatter for Tuesday September 24, 2013

    Benzinga
  34. Benzinga's Top Initiations

    Benzinga
  35. Benzinga's M&A Chatter for Tuesday September 17, 2013

    Benzinga
  36. UPDATE: Stifel Initiates Coverage on Clovis Oncology, Awaiting More Attractive ...

    Benzinga
  37. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  38. Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes Lower

    Benzinga
  39. Mid-Morning Market Update: Markets Continue Cautious Rally; Jefferies Acquired ...

    Benzinga
  40. Benzinga's Top Pre-Market Losers

    Benzinga
  41. Health Care Sector Wrap

    FoxBusiness
  42. Health Care Sector Wrap

    FoxBusiness
  43. Clovis Oncology and Array BioPharma Announce Agreement to Discover Novel ...

    Benzinga
  44. Clovis Oncology Announces FDA Acceptance of Investigational New Drug Application ...

    Benzinga
  45. End-of-Day Market Summary for January 18, 2012

    Benzinga
  46. UPDATE: JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  47. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  48. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
Trading Center